MEI Pharma’s (MEIP) zandelisib Has Best-in-Class Potential, Poised to Dominate the Space - Analyst
Go back to MEI Pharma’s (MEIP) zandelisib Has Best-in-Class Potential, Poised to Dominate the Space - Analyst| MEI PHARM (NASDAQ: MEIP) | Delayed: 3.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.07 | 52 Week High | $2.28 | |||
| Open | $3.07 | 52 Week Low | $0.87 | |||
| Day High | $3.07 | P/E | N/A | |||
| Day Low | $3.07 | EPS | $-0.88 | |||
| Volume | 239,798 | |||||
